Susquehanna International Group
NWBO

Susquehanna International Group’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Susquehanna International Group’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-162,300
Closed -$88K – 10726
2016
Q3 		$88K Sell
162,300
-41,300
-20% -$18.9K ﹤0.01% 7992
2016
Q2 		$118K Sell
203,600
-41,200
-17% -$44K ﹤0.01% 7950
2016
Q1 		$357K Sell
244,800
-265,200
-52% -$523K ﹤0.01% 6983
2015
Q4 		$1.63M Sell
510,000
-763,400
-60% -$3.67M ﹤0.01% 4451
2015
Q3 		$7.96M Sell
1,273,400
-116,600
-8% -$1.09M ﹤0.01% 2094
2015
Q2 		$13.8M Buy
1,390,000
+672,600
+94% +$5.89M 0.01% 1654
2015
Q1 		$5.29M Buy
717,400
+436,400
+155% +$2.94M ﹤0.01% 2664
2014
Q4 		$1.5M Sell
281,000
-40,300
-13% -$206K ﹤0.01% 5028
2014
Q3 		$1.62M Sell
321,300
-267,900
-45% -$1.65M ﹤0.01% 5009
2014
Q2 		$3.95M Buy
589,200
+320,000
+119% +$2.04M ﹤0.01% 3466
2014
Q1 		$1.95M Buy
269,200
+200,600
+292% +$1.19M ﹤0.01% 4404
2013
Q4 		$259K Buy
68,600
+33,900
+98% +$131K ﹤0.01% 7829
2013
Q3 		$116K Buy
+34,700
New +$121K ﹤0.01% 8033

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
MBT
Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BW
Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Susquehanna International Group's NWBO Position: Q4 2016 in Review

Susquehanna International Group sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 186,083 shares — an estimated $101K sold.

Susquehanna International Group first reported a position in NWBO in Q4 2013 and held it in 12 quarters. The position peaked at $6.75M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Susquehanna International Group reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Susquehanna International Group sold 186,083 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $101K.
  • Susquehanna International Group first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2013 and held it in 12 quarters.
  • Susquehanna International Group's Northwest Biotherapeutics, Inc. Common stock position peaked at $6.75M in Q2 2015.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.